M. López-Fagúndez

Caffeine, a Risk Factor for Osteoarthritis and Longitudinal Bone Growth Inhibition

R. Gómez, O. Gualillo, A. Alonso-Pérez, 2020, Journal of clinical medicine.

Amitriptyline blocks innate immune responses mediated by toll‐like receptor 4 and IL‐1 receptor: Preclinical and clinical evidence in osteoarthritis and gout

R. Gómez, O. Gualillo, A. Alonso-Pérez, 2021, British journal of pharmacology.

Effect and Regulation of Obesity-Associated Low-Grade Chronic Inflammation in Major Rheumatic Diseases

R. Gómez, A. Alonso-Pérez, M. Guillán-Fresco, 2022, Rheumato.

Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells.

R. Gómez, O. Gualillo, S. Bravo, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Improved Protocol to Study Osteoblast and Adipocyte Differentiation Balance

A. Alonso-Pérez, E. Franco-Trepat, M. Guillán-Fresco, 2022, Biomedicines.

β Boswellic Acid Blocks Articular Innate Immune Responses: An In Silico and In Vitro Approach to Traditional Medicine

R. Gómez, A. Alonso-Pérez, E. Franco-Trepat, 2023, Antioxidants.

The Hepatokine RBP4 Links Metabolic Diseases to Articular Inflammation

A. Alonso-Pérez, E. Franco-Trepat, M. Guillán-Fresco, 2024, Antioxidants.